Retinal volume change is a reliable OCT biomarker for disease activity in neovascular AMD
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Retinal volume change is a reliable OCT biomarker for disease activity in neovascular AMD
Authors
Keywords
AMD, OCT, Biomarker, VEGF; PRN, Macula, Retina
Journal
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-06-19
DOI
10.1007/s00417-018-4040-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Automatic Choroidal Layer Segmentation Using Markov Random Field and Level Set Method
- (2017) Chuang Wang et al. IEEE Journal of Biomedical and Health Informatics
- Automated Identification of Lesion Activity in Neovascular Age-Related Macular Degeneration
- (2016) Usha Chakravarthy et al. OPHTHALMOLOGY
- A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration
- (2016) Ursula Schmidt-Erfurth et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Outer retinal tubulations response to anti-VEGF treatment
- (2015) Mark Espina et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Stratified Sampling Voxel Classification for Segmentation of Intraretinal and Subretinal Fluid in Longitudinal Clinical OCT Data
- (2015) Xiayu Xu et al. IEEE TRANSACTIONS ON MEDICAL IMAGING
- Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol
- (2015) Karina Berg et al. OPHTHALMOLOGY
- REFRACTORY INTRARETINAL OR SUBRETINAL FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIZUBIMAB
- (2015) Christina Gianniou et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- OUTER RETINAL TUBULATION IN ADVANCED AGE-RELATED MACULAR DEGENERATION
- (2015) Karen B. Schaal et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
- (2014) Ursula Schmidt-Erfurth et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration
- (2014) Allen C. Ho et al. OPHTHALMOLOGY
- Die Anti-VEGF-Therapie bei der neovaskulären altersabhängigen Makuladegeneration: Therapeutische Strategien Stand Dezember 2012
- (2013) D. Pauleikhoff et al. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Outer Retinal Tubulation
- (2009) Sandrine A. Zweifel ARCHIVES OF OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now